Which of the following drug is commonly used in treatment for cancer associated thromboembotismt
Low molecular weight heparin
anti-thrombin III inhibitors
Direct Xainhibitors
Warfarin
Ans: A. Low molecular weight heparinCurrent guideline-endorsed therapy options for cancer-associated thrombosis include low molecularweight heparin (LMWH), unfractionated heparin (UFH), warfarin & fondaparinux.All current guidelines recommend LMWH for at least 3-6 months in cancer-associated VTE.